Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases

Location:	Federal
Posted:	Dec 23, 2025
Agency:	HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Contract:	Awards
Type of Government:	Federal
Category:	A - Research and development Q - Medical Services
Solicitation No:	7529
Publication URL:	To access bid details, please log in.

Active

Contract Opportunity

Notice ID

7529

Related Notice

Contract Line Item Number

Department/Ind. Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier

NATIONAL INSTITUTES OF HEALTH

Office

NATIONAL INSTITUTES OF HEALTH NIAID

Award Details

Contract Award Date: Sep 29, 2025
Contract Award Number: 75N93025C00025
Task/Delivery Order Number:

Contractor Awarded Unique Entity ID: NGZ6HVXE5MX4

Contractor Awarded Name: GENOMIC LABS LTD
Contractor Awarded Address: Bristol BS2 0JZ GBR
Base and All Options Value (Total Contract Value): $3,490,083.00

General Information

Contract Opportunity Type: Award Notice (Original)
Original Published Date: Dec 21, 2025 07:43 pm EST
Inactive Policy: Manual
Original Inactive Date: Jan 01, 2026
Initiative:
- None

Classification

Original Set Aside:
Product Service Code:
NAICS Code:
Place of Performance:
BS2 0JZ

GBR

Description

This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.

Attachments/Links

Contact Information

Contracting Office Address

5601 FISHERS LANE, SUITE 3D11
BETHESDA , MD 20892
USA

Primary Point of Contact

Secondary Point of Contact

History

Dec 21, 2025 07:43 pm ESTAward Notice (Original)

Related Document

Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] A--EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases
Dec 23, 2025	[Award Notice (Original)] Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases

Daily notification on new contract opportunities

With GovernmentContracts, you can:

Find more opportunities and win more business
Receive daily alerts for all new bid opportunities
Get contract opportunities matched to your business

ONE WEEK FREE TRIAL

Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases

Related Document

See also